Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CRISPR-Cas9 as a Tool in Cancer Therapy.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019

Same author

Synthetic Lethality - Its Current Application and Potential in Oncological Treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019

Same author

Glycosylation as an Important Regulator of Antibody Function.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019

Same author

Protein Ubiquitination Research in Oncology.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019

Same author

Oncogenic Viral Protein Interactions with p53 Family Proteins.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019

Same author

Cooperation of Genomic, Transcriptomics and Proteomic Methods in the Detection of Mutated Proteins.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019

Search research articles

Related Experiment Video

Updated: May 27, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

[Hsp90--a target for anticancer therapy].

E Růcková¹, P Müller, B Vojtesek

¹Masarykův onkologický ustav, Brno.

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti

|November 11, 2011

Summary

Molecular chaperones, particularly Heat Shock Protein 90 (Hsp90), are crucial for cancer cell survival by stabilizing mutant proteins. Inhibiting Hsp90 shows promise as an anticancer therapy due to its selective action on tumor cells.

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

Related Experiment Videos

Last Updated: May 27, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

Area of Science:

Molecular biology
Cellular stress response
Oncology

Context:

Molecular chaperones maintain protein conformation, aiding transport or degradation.
Cancer cells exhibit increased chaperone activity, stabilizing mutant proteins and overcoming genetic instability stress.
Tumor microenvironments, including hypoxia and nutrient deficiency, heighten cancer cell dependence on chaperones.

Purpose:

To highlight the critical role of molecular chaperones, especially Hsp90, in cancer cell biology.
To explore the potential of Hsp90 as a therapeutic target for anticancer strategies.
To discuss the differential sensitivity of tumor-associated Hsp90 to inhibitors compared to normal cells.

Summary:

Heat Shock Protein 90 (Hsp90) is a key molecular chaperone in cancer, stabilizing critical client proteins like growth factor and steroid hormone receptors.
Tumor cells rely heavily on Hsp90 to manage proteotoxic stress induced by adverse microenvironmental conditions.
Inhibition of Hsp90 in tumors suppresses oncogenic signaling pathways, offering a targeted therapeutic approach.

Impact:

Hsp90 inhibitors demonstrate significant potential in preclinical and clinical anticancer therapy development.
Targeting Hsp90 exploits the heightened dependence of cancer cells on this chaperone for survival.
Further research into Hsp90 inhibitors could lead to novel treatments for various cancers, with ongoing clinical evaluations and discovery of new agents.